Explore the updated Immunization Delivery Cost Catalogue (IDCC) and analyses; the most comprehensive, standardized global evidence on the cost of vaccine delivery

An analysis of immunization financing and performance in the Middle East and North Africa region just prior to the Arab Spring until 2017. It focuses on what we can learn about the financing challenges faced by countries. 

Join us for our iHEA pre-Congress workshop: The Benefit-Cost Analysis Reference Case: What It Is and How to Use It. This workshop provides an opportunity to learn more about new methodological guidance, including examples. 

The Society for Benefit-Cost Analysis will be holding its first European conference at the Toulouse School of Economics on November 26-27, 2019. The organizers welcome submissions on immunization economics and other work. 

Researchers recommend establishing a new multidisciplinary Global Technical Council on Infectious Disease Threats to better coordinate international management of volatile infectious disease risks and their consequences.

As the world moves into the Sustainable Development Goals, the Alliance’s 2021-25 strategy (“Gavi 5.0”) is an opportunity to contribute to the SDG vision of “healthy lives” and “leaving no one behind”.

Read the Journal for Benefit-Cost Analysis open-access special issue “Benefit Cost Analysis in Low- and Middle-Income Countries: Methods and Case Studies” and draft BCA reference case guidance. Draft comments are due by March 29, 2019

Draft guidelines for conducting benefit-cost analysis in low- and middle-income countries are now available for review. Comments are due March 29, 2019. 

Join us on March 15th to hear Dean Jamison speak on “Valuing Investments in Health for Development: Reflections on Three Dynamic Decades” at the Society for the Benefit Cost-Analysis annual meeting in Washington, D.C.

The EPIC project is proud to announce the Sample Design Optimizer (SDO) instrument. This instrument aims to assist research teams develop cost-effective and efficient sample design to maximize expected precision within a data collection budget constraint.

Get an overview of transitioning countries’ progress with LNCT’s new transition dashboards. See progress and challenges across LNCT countries and detailed progress for each country, compared with the LNCT group of countries.

Using examples from immunizations, a recent TVEE training focuses on develop skills in economic evaluations, carrying out a cost-effectiveness/budget impact analysis, and building local capacity in vaccine economics 

A new working paper provides a practical guide on immunization costing primary data collection and analysis. We would like to invite the Immunization Economics community to explore the working paper and provide feedback

Did you know that the models developed by the DOVE project estimate the costs averted by vaccination? The models focuses on ten antigens and 94 low- and middle-income countries, 2001-2030. Results are used at the global and regional level to advocate for new vaccine introduction and increased coverage.

We identified these 10 articles related to the economics of immunization. These articles were gathered from the START Center Vaccine Delivery Research Digest resource — up to the latest issue in January 2019

Immunization spending data play a key role in informing policy and planning. In this recently published webinar video, panel of experts discuss how countries can better produce, analyze, and present immunization spending data.

The Immunization Costing Action Network (ICAN) will develop methodological guidance and a customizable costing tool to support the costing of immunization campaigns. They will also conduct 3 campaign costing studies this year. You are invited to provide input.

New video features the Immunization Costing Action Network (ICAN). The ICAN bridges critical gap in immunization economics policymaking and implementation through their country work and cost catalogue

In this Learning Network for Countries in Transition (LNCT) blog, R4D’s Helen Saxenian, Leah Ewald, and Meghan O’Connell and Logan Brenzel from the Gates Foundation outline 4 things ministers of finance need to know about immunization in Gavi transitioning countries

New research looking into the extra dividends of vaccination will formally quantify the broad benefits of measles vaccination on childhood health,and the long-term labor-market gains.